KC-Matrix consists of cultured autologous keratinocytes and melanocytes in a collagen matrix. KC-matrix completed a prospective clinical phase II study in healing severe burn wounds. The promising results show on wound repair and the quality of scar formation is being analyzed.
In future KC-Matrix will be in a multicenter Phase II/III trial for surgical and trauma wounds and burn wounds to improve scar formation and wound repair.
Since 2013 A-SKIN has a granted a Hospital Exemption license of The Dutch Health Care Inspectorate (IGZ). KC-Matrix can be applied for clinical use to patients with a severe burn wound. Collaborating partner is the Association of Dutch Burn wound Centers.
Interested, more information: please contact A-SKIN.